Confirmed Speakers

Dr Roy Baynes, SVP, Global Clinical Development, Merck Sharpe & Dohme

Donnie McGrath, Vice President, Head Search & Evaluation, Business Development,

Bristol-Myers Squibb

Dr Cedrik Britten, Head Cellular Therapy, Immuno-Oncology, GlaxoSmithKline

Dr Sam Fazeli, Senior Pharmaceutical Analyst & European Head, Bloomberg Intelligence

Dr Nick Crabb, Programme Director, Scientific Affairs, National Institute for Health &

Clinical Excellence (NICE) – UK

Dr Detlev Parow, Head of Department, Care Management Development, DAK-Gesundheit

Dr. Michael S. Perry, Chief Scientific Officer, Global Business Development & Licensing

(BD&L), Novartis

Andre Choulika, Chairman & CEO, Cellectis

James Noble, CEO, Adaptimmune

Shawn Tomasello, Chief Commercial Officer, Kite Pharma

Dr Lothar Germeroth, Senior Vice President & Managing Director, Juno Therapeutics

GmbH

Niels Emmerich, Senior Director, Global Head Search & Evaluation Oncology, Abbvie, Inc

Dr Hans Klingemann, Vice President, R&D, NantKwest, Inc

Dr Paul Robbins, Senior Director, Translational Development, Pfizer, Inc

Dr Hazel Jones, Head of Combination Therapies, Cancer Research UK

Dr Joshua Resnick, Partner, SV Life Sciences

Dr Kristina Kakalacheva, Associate, Nextech Invest Ltd

Dr Vincent Brichard, Venture Partner, LSP (Life Sciences Partners)

Steven King, President & CEO, Peregrine

Dr Richard Morgan, VP Immunotherapy, bluebird bio

Dr Jeff Evelhoch, Vice President, Translational Biomarkers, Merck, Sharp & Dohme

Dr Andrea Van Elsas, Chief Scientific Officer, Aduro Biotech Europe

Peter Hoang, SVP, Business Development & Strategy, Bellicum Pharmaceuticals

Giovanni Mariggi, Principal, Medicxi Ventures

Dr Stefan Wildt, Vice President, Global Head Technical Research & Development, Cell &

Gene Therapies, Novartis

Dr Kai Pinkernell, Chief Medical Officer, Medigene

Dr Helen Tayton-Martin, COO, Adaptimmune

Dr Jens-Peter Marschner, CMO, Affimed

Dr César Hernández-Garcia, Head of Department, Department of Medicines for Human

Use, Spanish Medicine Agency (AEMPS) - Spain

Dr Lex Bakker, SVP & Chief Development Officer, Merus

Dr AnnChristine Thastrom, Clinical Scientist, PDO Clinical Development, Genentech, Inc

Dr Pierre Busson, Group Leader, Tumor Microenvironment, Exosomes & microRNAs in

Solid Tumors, Gustave Roussy

Dr Marc Matar, Partner, Simon-Kucher & Partners

Prof Martin Schuler, Director, Cancer Centre, University Hospital Essen

Dr Maria Cristina Galli, Chair of the ATMP Platform, EATRIS-ERIC, the European

Infrastructure for Translational Medicine; Department of Cell Biology & Neurosciences,

Istituto Superiore di Sanità, Italy

Dr Miguel Forte, Chief Operating Officer, TxCell SA

David Cocker, Senior Partner & Chief Scientific Officer, MDC Partners

Dr Tony De Fougerolles, Chief Scientific Officer, Ablynx

Dr Thomas Hoeger, Chief Executive Officer, Apogenix AG

Frederic Ors, CEO, Immunovaccine

Dr Luise Weigand, Team leader, Cell Biology/ Research Management, Immunocore Ltd

Dr Nina Kotsopoulou, Director, Process Development, Autolus

Linda Powers, CEO, Northwest Biotherapeutics

Dr. Winfried Wels, Professor for Tumor Biology and Deputy Director, Georg-Speyer-

Haus, Institute for Tumor Biology and Experimental Therapy Frankfurt, Germany

Dr Torsten Tonn, CEO, German Red Cross Blood Donation Service North-East;

Professor Transfusion Medicine, Dresden University of Technology

Dr Madhusudan Peshwa, Chief Scientific Officer, Maxcyte

Denis Dufrane (MD, MsC,PhD), Chief Scientific Officer & Co-Founder, Novadip

Biosciences

Professor Dr Martin Hildebrandt, Director of Manufacturing Facility, Qualified Person,

Technischen Universität München (TUM)

Dr Werner Lubitz, Chief Executive Officer & Chief Scientific Officer, BIRD-C GmbH

Jean-Philippe Combal, Chief Operating Officer, GenSight Biologics

Ajan Reginald, Chief Executive Officer, Cell Therapy Limited

Dr Anthony Davies, President, Dark Horse Consulting

Dr Christopher Bravery, Director, Advanced Biologicals Ltd

Dr Ohad Karnieli, Founder & CTO, Karnieli Ltd; Chair, Process & Product Development

Committee, ISCT

Louis Juliano, Senior Vice President, Global Sales & Business Development, HemaCare

Corporation

Dr Arnaud Lacombe, Project Manager, MaSTherCell

Ulrike Verzetnitsch, Chief Technical Officer, apceth GmbH & Co. KG